Marina Biotech Expands Global Patent Protection of Clinical Stage Nucleic Acid Delivery Technologies
23 avr. 2015 08h00 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Apr 23, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today it has...
Marina Biotech Provides 2014 Year-End Financials and Update
25 févr. 2015 08h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Feb 25, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported year-end...
Marina Biotech and MiNA Therapeutics Announce License Agreement for the Development of saRNA-Based Therapeutics
18 déc. 2014 08h00 HE
|
Marina Biotech, Inc.
BOTHELL, WA and SAN DIEGO, CA--(Marketwired - Dec 18, 2014) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, and...
Marina Biotech Reports That Licensee ProNAi Therapeutics Presented Interim Phase 2 Data on Its BCL2-Targeting DNAi(R) Therapeutic at ASH 2014
09 déc. 2014 08h00 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Dec 9, 2014) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that its...
Marina Biotech Reports That Partner Mirna Therapeutics Presented Interim Phase 1 Data on Its First-in-Class microRNA-34 Mimic
20 nov. 2014 08h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Nov 20, 2014) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that its...
Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance
18 nov. 2014 08h00 HE
|
Marina Biotech, Inc.
PRINCETON, NJ and REHOVOT, ISRAEL and BOTHELL, WA--(Marketwired - Nov 18, 2014) - Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics and...
Marina Biotech Announces Third Quarter 2014 Financial Results
17 nov. 2014 07h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Nov 17, 2014) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported...
Marina Biotech Announces the Election of Donald A. Williams to Its Board of Directors
16 sept. 2014 07h30 HE
|
Marina Biotech, Inc.
BOSTON, MA--(Marketwired - Sep 16, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today...
Marina Biotech Announces the Continued Worldwide Expansion of Its Delivery Technology Intellectual Property Estate
11 sept. 2014 07h30 HE
|
Marina Biotech, Inc.
BOSTON, MA--(Marketwired - Sep 11, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today...
Marina Biotech to Present Rare Disease Clinical Strategy at Upcoming Investor Conferences
03 sept. 2014 07h30 HE
|
Marina Biotech, Inc.
BOSTON, MA--(Marketwired - Sep 3, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that...